How to Read a Probiotic Label: What Does CFU Count Actually Mean?
Posted by The CodonRX Science Team on Jun 3rd 2026
Walk through the probiotics section of any Target or Walmart. You'll see numbers that escalate like a bidding war: 10 billion, 50 billion, 100 billion, 200 billion CFUs. The implicit message is clear — more is better, and the highest number wins.
This is one of the most misleading conventions in the supplement industry.
What Does CFU Count Actually Mean?
CFU stands for colony-forming units — a measure of viable, living bacteria capable of reproducing. A probiotic labeled “50 billion CFU” contains approximately 50 billion live bacterial cells per dose at the time of manufacturing (or at the expiration date, depending on how the label is written — these are not the same thing).
CFU is a total count across all strains in the capsule — and that creates a problem most labels don’t mention. A faster-multiplying strain can dominate the blend, claiming a disproportionate share of the total CFU and leaving slower strains unable to reach a minimum effective dose. What’s advertised as a multi-strain formula may function, in practice, as a single dominant strain with trace amounts of the rest.
More fundamentally, CFU count tells you almost nothing about whether those bacteria will do anything useful in your gut — and for people with IBS, it leaves out the single property that may matter most.
A probiotic with 200 billion CFUs of the wrong strain is not better than 10 billion CFUs of the right one. The number is meaningful only after you’ve established that the strain itself is appropriate for your situation.
Does Having More Probiotic Strains Mean Better Results for IBS?
Alongside CFU count, strain count has become the other major marketing metric. Products advertise “15 strains!” or “24 strains!” as evidence of comprehensiveness.
The logic is intuitive: a diverse microbiome is associated with better gut health, so a probiotic with many strains must provide more benefit. The problem is that this is not how probiotic biology works.
Most commercial multi-strain probiotics combine species based on manufacturing convenience and consumer perception rather than on clinical evidence that these specific strains work synergistically in humans. Research on multi-strain formulations is sparse, and the few studies that exist show mixed results — some combinations work, others don’t, and most haven’t been tested at all.
More importantly, all gram-positive probiotic bacteria — which includes every Lactobacillus and Bifidobacterium species on the market — carry a pro-inflammatory molecule called lipoteichoic acid (LTA) on their cell walls. A 15-strain probiotic isn’t delivering 15 types of benefit; it’s delivering 15 simultaneous sources of LTA. For people with IBS, whose gut lining is already in a heightened inflammatory state, this matters considerably.
How to Read a Probiotic Label
These are the four things worth checking — and what each one actually tells you:
| What to Check | What It Actually Tells You |
|---|---|
| CFU Count | Total bacteria per dose — not quality or strain fit. Look for “guaranteed at expiration,” not “at time of manufacture.” The latter may be significantly depleted by the time you open the bottle. |
| Strain Designation | The alphanumeric code after the species name (e.g., NCK2025™). This is the only thing that can be matched to published research. Most products omit it — if there’s no code, there’s no way to verify what’s been studied. |
| Number of Strains | Not a quality measure. In multi-strain blends, faster-multiplying strains can crowd out others before they reach an effective dose. No evidence shows that more strains produce better IBS outcomes. |
| LTA Content | Never disclosed on any label — but every standard gram-positive probiotic carries LTA. For a reactive IBS gut, LTA triggers the same inflammatory response already driving your symptoms. It’s the most important variable no label mentions. |
Why Does Your Probiotic Strain Matter More Than CFU Count?
The best-studied example of strain-level differences is the distinction between wild-type Lactobacillus acidophilus and its LTA-deficient counterpart, NCK2025™. Both are L. acidophilus. The difference is a single structural change— NCK2025™ is precision engineered without LTA.
Research published in PNAS (2011) showed that this single change produces a fundamentally different immune response in the gut: wild-type L. acidophilus stimulates pro-inflammatory molecules to be produced; the LTA-deficient NCK2025™ does not.1 The strains are biologically near-identical — but their interaction with an inflamed gut is categorically different.
This is the kind of distinction that CFU count, strain count, and “clinically studied” marketing language cannot capture. It requires knowing the specific strain and what the research actually says about it.
Discover what CodonRX can do for you.
Shop CodonRX® — $85 30-day supply · Patented NCK2025™ · Made in the USAReferences & Notes
- Mohamadzadeh M, et al. “Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid.” Proceedings of the National Academy of Sciences (PNAS). 2011;108 Suppl 1:4623–30. Demonstrates that LTA-deficient NCK2025™ produces a fundamentally different inflammatory profile compared to wild-type L. acidophilus.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.